11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Quick evaluation of kinase inhibitors by surface plasmon resonance using single-site specifically biotinylated kinases.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In evaluating kinase inhibitors, kinetic parameters such as association/dissociation rate constants are valuable information, as are equilibrium parameters KD and IC50 values. Surface plasmon resonance (SPR) is a powerful technique to investigate these parameters. However, results are often complicated because of impaired conformations by inappropriate conditions required for protein immobilization and/or heterogeneity of the orientation of immobilization. In addition, conventional SPR experiments are generally time-consuming. Here we introduce the use of single-site specifically biotinylated kinases combined with a multichannel SPR device to improve such problems. Kinetic parameters of four compounds-staurosporine, dasatinib, sunitinib, and lapatinib-against six kinases were determined by the ProteOn XPR36 system. The very slow off-rate of lapatinib from the epidermal growth factor receptor and dasatinib from Bruton's tyrosine kinase and colony stimulating factor 1 receptor (CSF1R) were confirmed. Furthermore, IC50 values were determined by an activity-based assay. Evaluating both physicochemical and biochemical properties would help to understand the detailed character of the compound.

          Related collections

          Author and article information

          Journal
          J Biomol Screen
          Journal of biomolecular screening
          1552-454X
          1087-0571
          Mar 2014
          : 19
          : 3
          Affiliations
          [1 ] 1Carna Biosciences, Inc., Kobe, Japan.
          Article
          1087057113506051
          10.1177/1087057113506051
          24080257
          7e72214b-c69a-40ac-b5c1-9351f61cdb31
          History

          biotinylation,drug discovery,kinase inhibitor,surface plasmon resonance,tyrosine kinase

          Comments

          Comment on this article